S&P raises Boston Scientific

Standard & Poor's said it raised its ratings on Boston Scientific Corp., including the long-term corporate credit rating to A from A-, the unsecured bank loan rating to A from A- and the senior unsecured debt rating to A from A-. The short-term corporate credit rating was raised to A-1 from A-2.

The outlook is stable.

S&P said the upgrade recognizes the medical device manufacturer's enhanced prospects related to investments in established markets and new technologies, as well as the company's increased financial strength that mitigates against litigation risk.

The ratings reflect Boston Scientific's broad portfolio of market-leading, minimally invasive medical devices and its deep and diverse new product pipeline, which mitigates the risks of participating in extremely competitive technology markets, the agency said.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.